Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RT2720
Target Gene : SDCBP Host Cell : HeLa
Size : >1x106 cells/vial Validation : Sequencing
| Cat. No. | CSC-RT2720 |
| Description | This cell is a stable cell line with a homozygous knockout of human SDCBP using CRISPR/Cas9. |
| Target Gene | SDCBP |
| Host Cell | HeLa |
| Host Cell Species | Homo sapiens (Human) |
| Size | 1 vial (>10^6 cell/vial) |
| Validation | Sequencing |
| Storage | Liquid nirtogen |
| Shipping | Dry ice package |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Media Type | Cells were cultured in DMEM supplemented with 10% fetal bovine serum. |
| Growth Properties | Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Split at 80-90% confluence, approximately 1:4-1:6. |
| Freeze Medium | Complete medium supplemented with 10% (v/v) DMSO |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | SDCBP syndecan binding protein (syntenin) [ Homo sapiens ] |
| Gene Symbol | SDCBP |
| Synonyms | ST1; SYCL; MDA-9; TACIP18 |
| Gene Description | syndecan binding protein (syntenin) |
| GeneID | 6386 |
| Uni ProtID | O00560 |
| mRNA Refseq | NM_001007069.1 |
| Protein Refseq | NP_001007070.1 |
| Chromosome Location | 8q12 |
| Function | cell adhesion molecule binding; cytoskeletal adaptor activity; ephrin receptor binding; frizzled binding; glycoprotein binding; growth factor binding; interleukin-5 receptor binding; protein C-terminus binding; protein N-terminus binding; protein heterodimerization activity; protein homodimerization activity; syndecan binding; syndecan binding; |
| Pathway | Axon guidance, organism-specific biosystem; Developmental Biology, organism-specific biosystem; IL-5 Signaling Pathway, organism-specific biosystem; L1CAM interactions, organism-specific biosystem; Neurofascin interactions, organism-specific biosystem; Syndecan-1-mediated signaling events, organism-specific biosystem; Syndecan-2-mediated signaling events, organism-specific biosystem; |
| MIM | 602217 |
The SDCBP gene encodes a protein called syntenin-1, which is present in humans and plays a crucial role in cellular functions. One of the main functions of syntenin-1 involves organizing the cytoskeleton and membrane structure, which is essential for maintaining cell shape, stability, and intracellular trafficking. The interaction of this protein with adherens junctions and focal adhesions emphasizes its role in cell adhesion, which is essential for tissue integrity and signal transduction. In addition, syntenin-1 also affects the activation of transcription factors, affecting gene expression and cellular responses.
The SDCBP gene exhibits alternative splicing, resulting in multiple transcript variants encoding different isoforms of syntenin-1. Its expression has been found in various tissues, including the retinal pigment epithelium, visceral pleura, amniotic fluid, and skin. Notably, syntenin-1 interacts with several important proteins, such as EFNB1, GRIK1, GRIK2, Merlin, and TRAF6, among others. These interactions highlight its involvement in a wide range of signaling pathways and cellular mechanisms, such as positive regulation of transforming growth factor-β receptor signaling, intracellular signal transduction, and organization of the actin cytoskeleton.
The Human SDCBP Knockout Cell Line-Hela is a powerful tool to advance research in a variety of biomedical fields. The following are the main applications of this cell line:
1. Cancer Research: The Human SDCBP Knockout Cell Line-Hela provides a valuable model for studying the role of SDCBP (syndecan-binding protein) in cancer progression and metastasis. Since SDCBP is involved in cell adhesion, migration, and signaling pathways, knocking out this gene in Hela cells helps to elucidate its contribution to tumor biology.
2. Drug Screening: This knockout cell line can be used for high-throughput drug screening to identify potential therapeutic compounds that target pathways affected by SDCBP loss. By comparing the responses between wild-type and knockout cells, researchers can identify drugs that specifically modulate the relevant cellular mechanisms.
3. Signal Transduction Studies: SDCBP is known to interact with a variety of signaling molecules. Knockout cell lines serve as models for more precise studies of these signaling pathways, allowing scientists to understand how the loss of SDCBP affects signal transduction and downstream effects.
4. Gene Function Analysis: The human SDCBP knockout cell line-Hela is ideal for basic studies of gene function. Researchers can observe phenotypic changes due to SDCBP knockout, gaining insight into its physiological role and interactions with other cellular proteins.
5. Biomarker Discovery: By utilizing this cell line in proteomic and genomic studies, new biomarkers associated with the SDCBP pathway can be identified.
A: DMEM supplemented with 10% fetal bovine serum. <br> It is not required to add the selection antibiotics when culturing the KO cells.
A: The knockout cell product is validated by PCR amplification and Sanger Sequencing to confirm the mutation at the genomic level. Please find the detailed mutation info in the datasheet.
A: Single clonal cell.
A: No. This knockout cell product is generated using the CRISPR/Cas9 system to induce small insertions or deletions (indels) resulting in frameshift mutations. Although these frameshift mutations typically disrupt the coding gene, there is a possibility that the non-functional transcript may still be transcribed. Consequently, this could potentially yield misleading results when analyzed by RT-qPCR.
A: The cell line should be stored in liquid nitrogen for long-term preservation.
A: For most cases, we often keep at least 2 clones with different frameshift mutations. Please feel free to contact us to check if there are additional available clones.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
By studying SDCBP knockout cells, we can assess the impact of its absence on signaling pathways like the mitogen-activated protein kinases (MAPK) or phosphatidylinositol-3 kinase (PI3K) pathways. Good experimental results were obtained.
SDCBP knockout cells allow us to investigate the impact of its absence on disease-related pathways and mechanisms, offering potential novel therapeutic targets for neurodegenerative diseases. These cell lines are very helpful for our research.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.